Showing 1 - 2 of 2 trials – Showing only trials currently accepting patients
-
Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children
Stanford is currently accepting patients for this trial. -
Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas
Stanford is currently accepting patients for this trial.